Employing Attenuated & Killed Gram-Negative Bacteria to Induce NK-Mediated Anti-Tumor Immunity
Time: 11:00 am
day: Day 1 - Track B - AM
Details:
- Taking advantage of a rapidly cleared, multi-immune receptor agonist package to induce safe, systemic innate and adaptive immune activation in pre-clinical models (Pulse-Prime hypothesis)
- Confirmation of the Pulse-Prime hypothesis in an advanced solid tumor clinical trial
